Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 25,012 shares at $26.38 ($660K) on 2014-06-16, disclosed to the SEC on 2014-06-18.
Scheduled sale ($660k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.38 | 12,256 | $323K | 49.0% |
| 2 | $26.38 | 12,756 | $337K | 51.0% |
| Total | $26.38 avg | 25,012 | $660K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |